Reducing Exposure to Opioid and Benzodiazepine Medications for Pediatric Cardiac Intensive Care Patients: A Quality

Amy Donnellan1, Jaclyn Sawyer2, Anne Peach1

  • 1Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Insights

A new comfort algorithm for pediatric cardiac surgery patients reduced opioid and benzodiazepine use. This quality improvement project demonstrated safer medication management without impacting patient outcomes.

Area of Science:

  • Pediatric Cardiac Surgery
  • Intensive Care Medicine
  • Pharmacology

Background:

  • Postoperative pain and anxiety management in pediatric cardiac surgery is complex.
  • Current practices may involve high doses of opioids and benzodiazepines.
  • Optimizing medication protocols can improve patient safety and care.

Purpose of the Study:

  • To evaluate the impact of a novel comfort algorithm on opioid and benzodiazepine infusion rates.
  • To assess the safety and efficacy of the algorithm in postneonatal pediatric cardiac surgery patients.
  • To improve medication management in a pediatric cardiac intensive care unit.

Main Methods:

  • A quality improvement project utilizing statistical process control methodology.
  • Implementation of a guided comfort medication algorithm including low-dose opioid infusions, judicious as-needed opioids, dexmedetomidine initiation, and minimal benzodiazepines.
  • Comparison of medication use before and after algorithm implementation in postoperative pediatric cardiac surgery patients.

Main Results:

  • Opioid infusion rates decreased post-implementation (73% vs 50%).
  • Benzodiazepine infusions were nearly eliminated.
  • No significant changes in dexmedetomidine use, duration of sedative infusions, mechanical ventilation, ICU stay, or unplanned extubations were observed.

Conclusions:

  • The pediatric comfort algorithm effectively reduced opioid and benzodiazepine dosing.
  • Medication adjustments were made without compromising patient safety or key clinical outcomes.
  • This algorithm represents a successful strategy for optimizing sedation and analgesia in pediatric cardiac surgery patients.
Abstract

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
292